Microsynth

Executive Summary

Microsynth is a Swiss life sciences company founded in 1989 that provides essential DNA/RNA synthesis, sequencing, and contract research services to academic and biotech clients across Europe. As a trusted service partner, it supports genetic and genomic research by offering high-quality, reliable laboratory services that accelerate scientific discovery. With over three decades of experience, Microsynth has established a strong reputation for technical expertise and customer service, positioning itself as a key enabler in the life sciences ecosystem. The company operates primarily as a service provider, generating recurring revenue from its client base and benefiting from the growing demand for outsourced genomic services. Despite being privately held and at a pre-clinical stage (meaning it does not develop its own therapeutics), Microsynth plays a critical role in the value chain, supplying tools and services that are fundamental to research and development. Its long track record and focus on quality give it a competitive advantage in the European market.

Upcoming Catalysts (preview)

• Q4 2026Launch of long-read sequencing service70% success
• Q3 2026Strategic partnership with a major pharmaceutical company for oligonucleotide synthesis50% success
• 2027Expansion of GMP-certified manufacturing facility for clinical-grade products80% success